California Pot Inspections Ramping Up
With the implementation of track-and-trace systems in the California cannabis industry expected to begin on June 1, state officials have started to get the ball rolling on enforcing the rules and regulations they developed over the last 17 months.
Simplifya Closes $3M Series B Round, Led By Merida Capital Partners
Leading cannabis industry compliance software, Simplifya closed a $3 million Series B funding round. This round was led with a $1.5 million investment from Merida Capital Partners.
U.S. Cannabis Investor Merida Capital Launches $75 Million Fund
Private equity firm Merida Capital Partners has deployed approximately $23 million into the cannabis industry over the past 15 months. Managing partner Mitch Baruchowitz, who got involved in the industry in 2010, worked with Theraplant to win one of four licenses in Connecticut and has been an investor in it since 2014, when he helped Leafline Labs attain one of the two licenses in Minnesota, spoke with New Cannabis Ventures about the firm’s Fund I investments and how that strong base is helping the company grow and diversify its portfolio.
Cannabis Compliance Company Simplifya Closes First Part of Series B Financing With $1 Million From Merida Capital Partners
Simplifya, a developer of regulatory compliance software for the cannabis industry, announced Thursday it has closed a lead investment of $1 million in its Series B financing from Merida Capital Partners, a private equity fund that targets fundamental growth drivers underpinning the rapid development of the cannabis industry. Additional investors are queued up to close the $3 million funding round.
Colorado Dominates Top 150 Ancillary Cannabis Companies
Legalizing cannabis doesn't just create jobs involving cultivation of the plant; it also creates businesses that aid those cultivations, infused-product manufacturers and dispensaries. Ancillary businesses to the cannabis industry can be in anything from extraction technology to industry consulting, with many, many things in between.
Jeff Sessions' Crusade Against Marijuana Just Hit a Huge Roadblock
Last week, the Senate Committee on Appropriations – the group that determines spending legislation in the Senate – reapproved an amendment that would keep U.S. Attorney General Jeff Sessions far away from medical marijuana.
The War on Drugs, The Business of Cannabis and The Judicial Horizon All Remain Murky
We have discussed in this column the explosive growth of the cannabis market, fueled by technology, a receptive market and legislative developments. But there is growing murkiness from the Administration about throttling this growth.
The Flourishing Industry of Cannabis Technology
As cannabis policies in the U.S. change, what was once a strictly underground business is now becoming increasingly legitimate and mainstream—and the industry is absolutely booming as a result.